Christopher Souza - Profile and Investment Details

Investor Profile

Christopher Souza is a Venture Capital, Private Equity Firm, Investor based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as Pulmokine Inc, SecurEnds, FineHeart, Provasculon, Laurantis Pharma, DecImmune Therapeutics, Gila Therapeutics, Herantis PharmaAria CV, CellAegis Devices Inc., Broadview Ventures, Remedy Pharmaceuticals, Apama Medical, CroíValve, ZZ Biotech, Allosteros Therapeutics Inc., Adient Medical, HAYA Therapeutics, Intravascular Imaging Incorporated, NIDO, G.I. Windows, NuPulseCV, 480 Biomedical, Cardero Therapeutics, Epirium Bio, Allosteros, AtaCor Medical, Alleviant Medical, CardiaLen, Aggamin Biologics, Metaome Science Informatics Pvt Ltd, Mellitus, Basking Biosciences, InfoBionic, Vectorious Medical Technologies, Ischemia Care, Capricor Therapeutics, CellAegis Devices, Renovacor, Giner Life Sciences, Vascular Graft Solutions, CardiAQ Valve Technologies, Antag Therapeutics, Ventrinova, Mellitus, LLC, Pulmokine, BioKier, Novartis, MassBio, Zumbro Discovery, Viridian Therapeutics, Acesion Pharma, Aeromics, . Over time, Christopher Souza has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Christopher Souza is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Enterprise Software, HR Tech, Android, Life Science, Small and Medium Businesses, Biotechnology, Consumer Health, Electronic Health Records (EHR), Health and Hospital Services, Clinical Trials, Consumer Internet, Digital Health, Medical, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Christopher Souza, as their portfolio suggests a familiarity and interest in this area.

Understanding Christopher Souza’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.